BECTON DICKINSON AND CO (BDX) 253.19 +3.03 (+1.21%)
253.19 +3.03 (+1.21%)
US0758871091 - Common Stock - After market: 253.19 0 (0%)
BECTON DICKINSON AND CO253.19
NYSE:BDX (2/7/2023, 7:26:11 PM)+3.03 (+1.21%)
| GICS Sector | Health Care | ||
| GICS Industry | Health Care Equipment & Supplies | ||
| Valuation | Growth | ||
| Profitability | Health | ||
| Dividend | |||
| Earnings (Last) | 02-02 2023-02-02/amc | Earnings (Next) | 05-03 2023-05-03/amc |
| Ins Owners | 0.15% | Inst Owners | 86.3% |
| Market Cap | 71.88B | Shares | 283.90M |
| PE | 21.88 | Fwd PE | 18.83 |
| Dividend Yield | 1.48% | Analysts | 77.27 |
| IPO | 09-25 1963-09-25 | ||
Stock Screener Links
New York Stock Exchange, Inc. Stock Screener
Find more stocks on New York Stock Exchange, Inc.
USA Stock Screener
Find more stocks on the USA
GICS Sector Stock Screener
Find competitors from the same sector on the USA
GICS Industry Stock Screener
Find competitors from the same industry on the USA
Technical Stock Screener
Find stocks with similar TA and Setup ratings on the USA
Fundamental Stock Screener
Find stocks with similar Fundamental rating on the USA
Best Technical Competitors Stock Screener
Find the competitors with the best technical ratings on the USA
Best Technical Setups Competitors Stock Screener
Find the competitors with the best technical and setup ratings on the USA
Best Fundamental Competitors Stock Screener
Find the competitors with the best fundamentals on the USA
Best Valuation Competitors Stock Screener
Find the competitors with the best valuation on the USA
Best Dividend Competitors Stock Screener
Find the competitors with the best dividend on the USA
Best Analyst Rating Competitors Stock Screener
Find the competitors with the best analyst ratings on the USA
Company Profile
Becton, Dickinson & Co. is a medical technology company. The company is headquartered in Franklin Lakes, New Jersey and currently employs 77,000 full-time employees. The firm operates through three business segments: BD Medical, BD Life Sciences and BD Interventional. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. BD Medical consists of various business units, including medication delivery solutions, medication management solutions, diabetes care and pharmaceutical systems. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. The BD Interventional segment provides vascular, urology, oncology and surgical specialty products.
Company Info
BECTON DICKINSON AND CO
One Becton Drive
Franklin Lakes NEW JERSEY 07417
P: 12018476800.0
CEO: Thomas E. Polen
Employees: 77000
Website: https://www.bd.com/
BDX News
4 days ago - Market News VideoNotable Friday Option Activity: HES, BDX, DISH
5 days ago - BD (Becton, Dickinson and Company)BD Introduces High-Throughput Single-Cell Multiomics Platform to Expand Scope of Scientific Discovery/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a new instrument for single-cell...
5 days ago - Seeking AlphaBecton, Dickinson quarterly results, guidance raises see Street approval (NYSE:BDX)Becton, Dickinson's (BDX) Q4 2022 financial results, which saw a beat on the top and bottom lines and a 2023 guidance lift, was met with approval by Street analysts.
6 days ago - BD (Becton, Dickinson and Company)BD Reports First Quarter Fiscal 2023 Financial Results/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced results for its first quarter of...
8 days ago - BD (Becton, Dickinson and Company)BD Named to Bloomberg Gender-Equality Index for 4th Consecutive Year/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has been named to the 2023...
14 days ago - BD (Becton, Dickinson and Company)BD Publishes 2022 Cybersecurity Annual Report/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today released its third annual cybersecurity...
BDX Twits
Here you can normally see the latest stock twits on BDX, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
